chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12/12: seen in urgent care, rash(hives), wheezing -- > got albuterol and zyrtec, COVID test neg.  Felt better until 12/14 -- > didn't take inhaler and had increased SOB, then chest pain/numbness -- >ER and per pt reprot had normal workup, urine, blood tests, CXR, EKG, sent home.  12/16 -- urgent care-- >ED, tired, lay down and had sharp pain in R upper back then R sided chest pain lasting 1 min folllowed by numbness of L arm and chest tightness, with mild SOB.  It got better when he stood up and walked around, then came back 2 more times with sitting down.  Numbness spread to legs. -- >ED COVID+ and Troponin elevated (0.1) admitted for myocarditis concern. Echo was normal, EKGs varied, and Troponin slowly trended down (not nL prior to discharge) and he still has chest pain although less severe (1/3/22 per mother).  He did not receive remdesivir or monoclonal ab.   He did have recurrence of his non-pruritic urticaria during this stay.  This is most likely be due to COVID but given date of last vaccine I thought I'd submit.  Mom is aware.
No adverse effects- patient was given initial Pfizer dose instead of the Pfizer Bivalent dose
Difficulty in breathing; I am sweating like a pig all time; Might be an allergic reaction, I mean I am sweating a lot; I am sweating like a pig all time; Might be an allergic reaction, I mean I am sweating a lot; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 21Apr2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Aug2021, the patient experienced difficulty in breathing, i am sweating like a pig all time; might be an allergic reaction, i mean i am sweating a lot. Patient stated that "I have the drug was the 21st of April and this is coming out with me now. I think that's something that you should be aware of". Patient took the test and it came up negative (further clarification unknown about the test). The outcome of the events was unknown.   Information about lot/batch number cannot be obtained. No further information expected.
This spontaneous report as received from a pharmacist refers to unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX (dose, route and site of administration, lot # and expiry date were not reported) for prophylaxis. No adverse effect reported. Additional information has been requested.
Patient is 16 years old and he received Moderna vaccine instead of Pfizer.  No treatment required. No signs or symptoms reported.
92 y.o. male patient with past medical history of Factor V with history of pulmonary embolism who presented with shortness of breath and cough. He was vaccinated for COVID-19 with his first shot on 2/3 followed by 2/27 with the Pfizer vaccine. He reported his symptoms started on 4/3. Family members including wife (also vaccinated) all had similar symptoms, they had all tested positive for COVID-19 on 4/6. He reports having diarrhea, nausea, shortness of breath and cough. No chest pain. Work up in the ED revealed a WBC of 16.1 and infiltrates on CXR.  Patient is admitted to hospital starting 4/9/21 and currently still here as of today 4/30/21.
Central Serous Chorioretinopathy  My first dose of the Pfizer vaccine was on April 22nd. A few days after vaccination, I experienced flashes in my right eye when I closed it. I then waited a few days to see if the flashes would go away. In the meantime, a persistent and fixed floater developed at the center of my right's vision. Flashes did go away. Alarmed, I went to the ophthalmologist where I was diagnosed with CSC and sent to an eye surgeon who had better imaging tech.  The eye surgeon tried the wait and see approach for 4 weeks. No change. I went back and was prescribed a mild blood pressure medication (Eplilaron 50mg a day) for 6 weeks. That did not have any effect on the floater. The eye surgeon then used a laser to treat my right eye. The floater has since disappeared.
pt recv vax 24OCT95 & w/in 1 hr devel an inj site rxn characterized as red,raised,warm & 3 inches in circumference
Tested her blood and it came back positive for syphilis / Repeated the test / Came back negative; This case was reported by a other health professional via call center representative and described the occurrence of syphilis test false positive in a 56-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2020-2021 season) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   The patient's past medical history included covid-19 (diagnosed in March 2020).   In October 2020, the patient received Fluarix Quadrivalent 2020-2021 season. On an unknown date, the patient started Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, less than 2 months after receiving Fluarix Quadrivalent 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced syphilis test false positive. On an unknown date, the outcome of the syphilis test false positive was unknown.   It was unknown if the reporter considered the syphilis test false positive to be related to Fluarix Quadrivalent 2020-2021 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: In early October 2020, the patient received Fluarix Quadrivalent vaccine. Following the vaccination, she provided provided blood and plasma for treatment of COVID patients, and the blood bank tested blood and it came back positive for syphilis.  When the laboratory repeated the test with another test, the test came back negative.  The reporter stated the blood bank told her sometime with the flu vaccine, the lab test gives them a false positive for syphilis. No additional information was provided. The reporter did not consent to follow up.
Patient states her first covid vaccine was given to her then she felt heart palpitations, sat down, and then she felt better. Declined water or a snack. No vital signs taken, patient states she felt better at 1045, and wanted to leave to get back to work.
Patient described her upper arm becoming very red, warm, and sore. Noticed it before going to bed a few hours after vaccine administered. Symptoms had mostly faded by time I saw her on Fri. 9-9-16.
Hives on right arm only. No SOB, no tachypnea, no mental status changes, no abd pain, no emesis. Hives limited to right arm only. Mildly itchy. Given Benadryl 25mg PO
24 hrs p/inject developed low grade fever (101), irritable, rash on arms, legs, palms & soles of feet; Rash was red w/raised areas; Self limiting sx; Did not see MD; Mom concerned w/continuing series;
Patient received Intranasal Influenza Vaccine at approximately 3:15 PM on 9/3/2009. By approximately 6:00 PM on 9/3/2009. patient complained of his upper lip feeling 'funny.' His upper lip was noticably swollen. Patient was given a frozen popsicle to help reduce the swelling. By approximately 7:00 PM, I observed patient's bottom lip had begun to swell. At that time, patient was given diphenhydramine 25mg by mouth. He continued to complain of discomfort to his lips. Patient denied shortness of breath, sore throat, itchiness & tongue symptoms. His nose and nares were mildly swollen. Patient went to sleep around 9:00 PM and slept uneventfully. I checked patient at 5:00AM today (9/4/2009), and his upper and bottom lips were still quite swollen. Patient was given another 25mg dose of diphendydramine. I will notify his provider when the clinic opens this morning.
Admission Date: 12/3/2022 Discharge Date: 12/8/2022 COVID positive date: 12/3/2022 PRESENTING PROBLEM: Generalized weakness COVID-19   HOSPITAL COURSE:    The patient is a 86 year old female with previous stage II lung adenocarcinoma and LU lobectomy in 2012 presents with worsening fatigue and shortness of breath. She was admitted with Covid and started on remdesivir and dexamethasone. She also had a history of pulmonary embolism, at that time she was treated with warfarin for several years and stopped.  She also was found to have paroxysmal atrial fibrillation around the time of the pulmonary embolism.  She has not been treated for either in several years and did have a Cardiology follow-up with negative workup for atrial fibrillation.   During hospital course, due to shortness of breath,  history of PE, history of lung Ca a CTA thorax was performed with significant findings. There is narrowing and obstruction of left bronchi which could be due to carcinoma, and has developed since the prior exam from 12/28/2021. Bronchoscopy is recommended. Soft tissue attenuation is seen along the posterior and posterolateral left heart border measuring 8.5 x 2.8 cm in the axial plane, and could represent postobstructive atelectasis and/or carcinoma. A moderate amount of groundglass opacity is seen in the left lower lobe compatible with pneumonia. Recommend to have repeat imaging in 4-6 weeks. She is scheduled to follow up with oncology in January. For the CAP, she received 5 days of ceftriaxone and azithromycin, will be discharged home with 2 additional days of azithromycin and ceftin for a 7 day course. She received five days of remdesivir and prednisone. On 12/7 multiple events of tachycardia (150s) Cardizem increased to 180 mg from 120 mg. Discuss to monitor blood pressure at home and to follow up with PCP. Physical therapy and occupational therapy recommend SAR and 4WW. Patient refused placement and will be returning home with the care of her daughter.    Patient seen and examined- alert and oriented. She is not requiring any supplemental oxygen. Reports slight fatigue and shortness of breath. Denies fever, chills, chest pain, abdominal pain. Patient is discharged in stable condition- all labs and imaging reviewed. No concerns at this time. All questions were answered prior to discharge
SWOLLEN LIPS; SWOLLEN THROAT; DIZZINESS; FLUSHED FACE; FLU-LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 59 year old male. The patient's weight was 194 (unit unspecified), and height was 71 inches. The patient's concurrent conditions included gout, alcohol use, non-smoker, cipro allergy, high cholesterol, and high blood pressure, and other pre-existing medical conditions included the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 08:00 in left arm for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication, febuxostat for drug used for unknown indication, losartan for drug used for unknown indication, pravastatin for drug used for unknown indication, probiotics nos for drug used for unknown indication, selenium for drug used for unknown indication, vitamin d nos for drug used for unknown indication, and calcium. On 08-MAR-2021, the subject experienced swollen lips. On 08-MAR-2021, the subject experienced swollen throat. On 08-MAR-2021, the subject experienced dizziness. On 08-MAR-2021, the subject experienced flushed face. On 08-MAR-2021, the subject experienced flu-like symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen lips, swollen throat, dizziness, and flushed face on 08-MAR-2021, and flu-like symptoms on 10-MAR-2021. This report was non-serious.
Information has been received from a consumer concerning his 11 month old son with no medical history and no drug allergies, who on 21-MAR-2007 was vaccinated with a first dose of Hib conj vaccine. Concomitant therapies included an unspecified vaccine.  On 17-JUL-2007 the patient received a second dose of Hib conj vaccine (OMPC). On 25-SEP-2007 the patient received a third dose of Hib conj vaccine (OMPC). It was reported that "about six months ago" in approximately June 2007, the patient experienced rash. No laboratory diagnostics were performed. At the time of the report, the patient had not recovered. No product quality complaint was involved. Additional information has been requested.
client complained swollen area about size baseball noted under left arm noticed soreness under arm to chest area . This was first noted on 05162009. client applied heat to area and said it came down to alittle smaller than golf ball on 05172009 and it is about the same today 05172009 there is some reddness noted under arm and firm area that is swollen under arm in lymph node area and soreness still there but has improved some.instructed client to see md and he said if doesn't con't to improve today he will see md.
Patient received first booster (3rd dose) of COVID vaccine on 5/6/2022. She calls the pharmacy on 5/8/22 to report adverse reactions, presumably due to the vaccination received on 5/6/22. Patient states no new drugs/food changes. Patient reports rash that goes from neck down to sternum of front, and rash that localizes around spinal area. She also states being sweaty and having a headache the last couple days. She also said she noticed a little stiff neck yesterday (5/7), but that went away on its own. She took tylenol the last 2 days to help with the headache. She denies any fever/chills, pain, or tingling sensation. Patient states the rash is a little itchy.  I advised patient to take diphenhydramine 50mg and to monitor for any fever, pain, or tingling sensation, spreading of rash, or difficulty breathing and to head to ER if they occur. Upon follow up with patient 1 hour after initial call on 5/8/22, she now reports slight chest heaviness and feels like throat is getting tight.  I advised she head to ER immediately.
No adverse effects were reported; patient received GARDASIL 9 on the following dates: an unspecified date in November 2017, 9/15/2018, and 10/29/2018; This spontaneous report was received from a pharmacist and refers to a 15-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On unspecified date in November 2017, 15-SEP-2018 and 29-OCT-2018, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) intramuscularly for prophylaxis (strength, dose, site, lot # and expiration date were not reported). No adverse effects were reported.
Report 20020017131 describe a viral syndrome in a 7 week old male who received diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed. This report was received from a nurse. Medical history included "difficult delivery: at gestational age 39 weeks and meconium aspiration treated with extracorporeal membrane oxygenation, mechanical ventilation, and continuous positive airway pressure. Concurrent conditions were not specified. Concurrent medications included paracetamol. On 10/31/2001, the infant received his first injection of Infanrix. On that date, he also received his first injection of 7-valent neumococcal conjugate vaccine combination haemophilus influenzae type b conjugate/hepatitis B vaccine and inactivated poliomyelitis virus vaccine. Eight hours post-immunization, the infant developed generalized hives and fever of 101 to 103 degrees F. He was hospitalized on 11/01/2001 with a diagnosis of viral syndrome. He was treated with diphenhydramine (Benadryl). He recovered on 11/02/01 and was discharged from the hospital on 11/03/2001. He was seen by his physician for follow-up and was treated with palivirumab (Syngais) on 11/05/01, 12/03/01, 12/31/01 and 01/29/02. The infant was evaluated by an allergist at a tertiary care center on 12/04/01. The allergist noted that, approximately one month following the viral syndrome, the infant developed "some mild atopic dermatitis" On examination, the allergist noted that "The arena of eczema was everywhere on his body  except for his groin, which is a typical pattern." The infant underwent "percutaneous skin tests... On skin testing, he was negative to cat, dog, dust mites,soy and peanut. He had an intermediate reaction to milk and eggs. i also reviewed his vaccines and his vaccines do not appear to have caused any of his reactions." The allergist recommend removing milk and egg from the infant's diet. On 01/03/02, the infant received his second injection of Infanrix (lot DTPA524A2), Prevnar and IPOL. He also received an injection of haemophilus influenzae type B conjugate vaccine (PedvaxHIB, Merck). Eight hours post-immunization, he again developed urticaria and fever. He was treated with diphenhydramine and recovered on 01/05/02. The most recent information was received from the vaccine provider on 02/25/02. The vaccine provider considered both episodes of urticaria and hives to be severe in intensity and possibly related to Infanrix administration.
BAG OF COVID-19 VIALS HAD A VIAL OF SHINGRIX IN IT. I ADMINISTERED 0.3ML SHINGRIX IN LEFT ARM AND COVID-19 IN RIGHT ARM
Patient received non diluted dose of Pfizer equaling .3. Was observed and no reaction.
24 HR S/P vaccine, patient developed an enlarging area of erythema/heat - not around injection site but distal to this over deltoid muscle distribution. Mildly tender to pressure; no drainage.
Patient was to receive Pfizer bivalent booster 0.2 ml 5-11 year old dose but instead received Pfizer bivalent booster 6 month to 4 year old dose. No adverse effect noted.
It started as diarrhea at 4:00 a.m. and around 5:00 am he started to vomit, with several vomiting episodes until 8 am. At 8 am I took his temperature, which was between 100.4 and 102.2 on a forehead thermometer. No treatment, but at 8 am he started to drink water and has kept that down. We both ate similar food last night (around 11:00 p.m.) at a friend's party, except he had one piece of fried chicken, and I didn't eat any fried chicken. At this point (10:30 a.m.) he still has a temperature between 100.4 and 102.2 but has not vomited since 8 am and he just now had a "normal" bowel movement (not diarrhea). He is complaining of aching joints.
Headache and nausea for 1 week, found to have cavernous sinus thrombosis on MRI 4/29/2021. Started on apixaban
15 hours after vaccine started with chills, fever 102-103 x 48 hours. Took Tylenol every 4 hours with little improvement of following symptoms: severe headache, nausea, dizziness. Got out of bed only for bathroom and needed help to walk there. In and out of reality with very strange dreams.  Still have foggy feeling and am not able to drive yet or go out.
VASOVAGAL- NAUSEA, FAINTNESS, SWEATING, PALENESS.
Systemic: Abdominal Pain-Medium, Systemic: Chest Tightness / Heaviness / Pain-Mild, Additional Details: Patient stated she was experiencing some \"pressure and swelling under her upper ribcage\" and that she has had this reaction in the past when she accidently inhaled some chemicals. Patient was given one dose of Epinephrine IM into her left thigh and felt relief in pressure after 3 minutes. Patient was advised that if she experiences other symptoms to go to the ER.
Cyst in right breast and Nodule in left breast. All this happened after taking 1st and 2nd Pfizer Vaccines dose. I was healthy and never had breast issues before.
This case was reported by a physician, via a GSK sales representative, that described the occurrence of injection site hot to touch in four child subjects of unspecified genders who were vaccinated with INFANRIX, GlaxoSmithKline. On an unspecified date, the subjects received either their 4th or their 5th dose of INFANRIX (.5ml, unknown). Within 24 hours after vaccination with INFANRIX, the subjects experienced injection site that was hot to touch, and swelling at the injection site. The physician's office reported that at least four child subjects experienced the same type of reaction to a particular lot of INFANRIX (lot# AC14B085BA). Product complaints were lodged for these reports, as the physician's office was concerned that this was a potentially a bad lot of INFANRIX. At the time of reporting, the outcome of the event was unspecified. The physician considered the events were probably related to vaccination with INFANRIX. Follow-up information received on 07 October 2008 indicated that the subject was a 4 year old male. The events began on 20 August 2008 and resolved on an unspecified date in August 2008. In the reporter's opinion, the events of injection site that was hot to the touch, and swelling at the injection site were possibly related to treatment with INFANRIX. In follow-up a 5th case was reported. Linked cases include: A0747164A, A0747167A, A0747168A and AC752555A. A safety statement received on 19 October 2008 concluded that there was no evidence for a safety signal or safety concern for the INFANRIX lot AC14B085BA.
Pt recv vax on 4/19/99; on same day pt exp vax site pain/ swelling; LUE was erythematous/ warm
This case was reported by a consumer via call center representative and described the occurrence of seizure of a 1-year-old male patient who received PEDIARIX (batch number 5XK44, expiry date 11th December 2016). Co-suspect products included ROTARIX (batch number A41CB465A, expiry date 4th February 2016). Concomitant products included Hib vaccine and PREVNAR 13. On 30th January 2015 11:30, the patient received the 2nd dose of PEDIARIX (intramuscular). On an unknown date, the dose was an unknown dose. On 30th January 2015 11:30, the patient received the 2nd dose of ROTARIX (oral). On 31st January 2015, 1 days after receiving PEDIARIX and ROTARIX, the patient experienced screaming. On 1st February 2015, the patient experienced seizure (serious criteria GSK medically significant). PEDIARIX was discontinued. ROTARIX was discontinued. On an unknown date, the outcome of the seizure and screaming were recovered/resolved. The reporter considered the seizure and screaming to be related to PEDIARIX and ROTARIX. Additional information received: This case was reported by a consumer via call center representative and described the occurrence of seizure in a 1-year-old male patient who received PEDIARIX (batch number 5XK44, expiry date 11th December 2016). Co-suspect products included ROTARIX (batch number A41CB465A, expiry date 4th February 2016). Concomitant products included Hib and PREVNAR 13. On 30th January 2015 11:30, the patient received the 2nd dose of PEDIARIX (intramuscular). On 30th January 2015 11:30, the patient received the 2nd dose of ROTARIX (oral). On 31st January 2015, 1 days after receiving PEDIARIX and ROTARIX, the patient experienced screaming. On 1st February 2015, the patient experienced seizure. PEDIARIX was discontinued on 30th January 2015. ROTARIX was discontinued on 30th January 2015. On an unknown date, the outcome of the seizure and screaming were recovered/resolved. The reporter considered the seizure to be related to PEDIARIX and ROTARIX. It was unknown if the reporter considered the screaming to be related to PEDIARIX and ROTARIX.
Pain in left vaccine arm, dizzy spells, chills, fever, diarrhea, headaches, stomach, and body pain.
Patient received immunization on 9/22/16 at approxim. 230pm. On 10/13/16 Patient reported adverse event. Patient stated 2 weeks after immunization she experienced swollen, bruised arm which was warm to the touch. She also experienced flu-like symptoms (coughing,/runny nose/aches/pains).
28JUL 430PM mom phoned clinic states was giving pt APAP & noticed that from naval down had truned blue for a few seconds; states pt seems ok kicking legs, looking around & no fever;
Severe chills with violent shaking which were unresponsive to Acetaminophen or aspirin. Lasted 24 hours.  Fever, Lethargy, Dizziness, which lasted 24 hours as well.